Latest & greatest articles for atrial fibrillation

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on atrial fibrillation or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on atrial fibrillation and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for atrial fibrillation

221. Bridging Anticoagulation in Patients with Atrial Fibrillation.

Bridging Anticoagulation in Patients with Atrial Fibrillation. Bridging Anticoagulation in Patients with Atrial Fibrillation. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager Format Create File 1 selected item: 26736008 Format MeSH and Other Data (...) E-mail Subject Additional text E-mail Add to Clipboard Add to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2016 Jan 7;374(1):92. doi: 10.1056/NEJMc1513255#SA4. Bridging Anticoagulation in Patients with Atrial Fibrillation. , , . Comment in [N Engl J Med. 2016] Comment on [N Engl J Med. 2015] PMID: 26736008 DOI: [Indexed for MEDLINE] Publication types MeSH terms Substances Full Text Sources Medical PubMed Commons

NEJM2016 Full Text: Link to full Text with Trip Pro

222. Bridging Anticoagulation in Patients with Atrial Fibrillation.

Bridging Anticoagulation in Patients with Atrial Fibrillation. Bridging Anticoagulation in Patients with Atrial Fibrillation. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager Format Create File 1 selected item: 26736009 Format MeSH and Other Data (...) E-mail Subject Additional text E-mail Add to Clipboard Add to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2016 Jan 7;374(1):92-3. doi: 10.1056/NEJMc1513255#SA5. Bridging Anticoagulation in Patients with Atrial Fibrillation. . Comment in [N Engl J Med. 2016] Comment on [N Engl J Med. 2015] PMID: 26736009 DOI: [Indexed for MEDLINE] Publication types MeSH terms Substances Full Text Sources Medical PubMed Commons 0

NEJM2016 Full Text: Link to full Text with Trip Pro

223. Cohort study: In people with atrial fibrillation receiving antithrombotics, short-term non-steroidal anti-inflammatory drug exposure increases risk of serious bleeding

Cohort study: In people with atrial fibrillation receiving antithrombotics, short-term non-steroidal anti-inflammatory drug exposure increases risk of serious bleeding In people with atrial fibrillation receiving antithrombotics, short-term non-steroidal anti-inflammatory drug exposure increases risk of serious bleeding | Evidence-Based Nursing This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal (...) accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here In people with atrial fibrillation receiving antithrombotics, short-term non-steroidal anti-inflammatory drug exposure increases risk of serious bleeding Article Text Adult nursing Cohort

Evidence-Based Nursing (Requires free registration)2016

225. Amiodarone method of administration for treatment of post-operative atrial fibrillation

Amiodarone method of administration for treatment of post-operative atrial fibrillation Amiodarone method of administration for treatment of post-operative atrial fibrillation Amiodarone method of administration for treatment of post-operative atrial fibrillation Mitchell MD, Strauss R, Mull N. Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database (...) . Citation Mitchell MD, Strauss R, Mull N.. Amiodarone method of administration for treatment of post-operative atrial fibrillation. Philadelphia: Center for Evidence-based Practice (CEP). 2016 Final publication URL Indexing Status Subject indexing assigned by CRD MeSH Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Postoperative Period Language Published English Country of organisation United States English summary An English language summary is available. Address for correspondence

Health Technology Assessment (HTA) Database.2016

226. Amiodarone for prevention of atrial fibrillation in cardiac surgery patients

Amiodarone for prevention of atrial fibrillation in cardiac surgery patients Amiodarone for prevention of atrial fibrillation in cardiac surgery patients Amiodarone for prevention of atrial fibrillation in cardiac surgery patients Mitchell MD, Reynolds CR, Mull N Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Mitchell MD, Reynolds CR (...) , Mull N. Amiodarone for prevention of atrial fibrillation in cardiac surgery patients. Philadelphia: Center for Evidence-based Practice (CEP). 2016 Final publication URL Indexing Status Subject indexing assigned by CRD MeSH Amiodarone; Atrial Fibrillation; Cardiac Surgical Procedures; Humans Language Published English Country of organisation United States English summary An English language summary is available. Address for correspondence Center for Evidence-based Practice, University

Health Technology Assessment (HTA) Database.2016

227. Cohort study: Still many unanswered questions about rate control therapy in atrial fibrillation

Cohort study: Still many unanswered questions about rate control therapy in atrial fibrillation Still many unanswered questions about rate control therapy in atrial fibrillation | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword (...) Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Still many unanswered questions about rate control therapy in atrial fibrillation Article Text Therapeutics/Prevention Cohort study Still many unanswered questions about rate control therapy in atrial fibrillation Mariëlle Kloosterman , Isabelle C Van Gelder Statistics from Altmetric.com No Altmetric data available

Evidence-Based Medicine (Requires free registration)2016

228. 2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter

2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter 2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter | Circulation: Cardiovascular Quality and Outcomes Search for this keyword Search Search for this keyword Search Header Publisher Menu ACC/AHA Performance Measures 2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter A Report (...) . McManus Robert L. McNamara Jump to Table of Contents Preamble 444 1. Introduction 445 1.1. Scope of the Problem 445 1.2. Disclosure of Relationships With Industry and Other Entities 446 2. Methodology 447 2.1. Literature Review 447 2.2. Definition and Selection of Measures 447 3. 2016 ACC/AHA Atrial Fibrillation/Atrial Flutter Clinical Performance and Quality Measures 448 3.1. Discussion of 2016 Atrial Fibrillation/Atrial Flutter Clinical Performance and Quality Measures 448 3.1.1. Retired Measures

American Heart Association2016

229. Cohort study: Restarting oral anticoagulation among patients with atrial fibrillation with gastrointestinal bleeding was associated with lower risk of all-cause mortality and thromboembolism

Cohort study: Restarting oral anticoagulation among patients with atrial fibrillation with gastrointestinal bleeding was associated with lower risk of all-cause mortality and thromboembolism Restarting oral anticoagulation among patients with atrial fibrillation with gastrointestinal bleeding was associated with lower risk of all-cause mortality and thromboembolism | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log (...) in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Restarting oral anticoagulation among patients with atrial fibrillation with gastrointestinal bleeding was associated with lower risk of all

Evidence-Based Medicine (Requires free registration)2016

230. Health technology assessment (HTA) of a national screening programme for atrial fibrillation in primary care

Health technology assessment (HTA) of a national screening programme for atrial fibrillation in primary care Health technology assessment (HTA) of a national screening programme for atrial fibrillation in primary care Health technology assessment (HTA) of a national screening programme for atrial fibrillation in primary care Health Information and Quality Authority Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation (...) of the quality of this assessment has been made for the HTA database. Citation Health Information and Quality Authority. Health technology assessment (HTA) of a national screening programme for atrial fibrillation in primary care. Dublin: Health Information and Quality Authority. 2015 Authors' objectives The terms of reference for the HTA were: - to review the international clinical evidence on the effectiveness and safety of screening for atrial fibrillation, - to review the available literature on the cost

Health Technology Assessment (HTA) Database.2016

231. Neutrophil to lymphocyte ratio and risk of a first episode of stroke in patients with atrial fibrillation: a cohort study

Neutrophil to lymphocyte ratio and risk of a first episode of stroke in patients with atrial fibrillation: a cohort study 25988740 2015 11 09 2016 09 16 2015 11 09 1538-7836 13 11 2015 Nov Journal of thrombosis and haemostasis : JTH J. Thromb. Haemost. Neutrophil to lymphocyte ratio and risk of a first episode of stroke in patients with atrial fibrillation: a cohort study. 1971-9 10.1111/jth.13006 The neutrophil to lymphocyte ratio (NLR) is associated with increased risk of cardiovascular (...) morbidity and mortality. We aimed to assess the association between NLR and first episode of stroke in patients with atrial fibrillation. Using the computerized database of the largest HMO in Israel, we identified a cohort of adults, aged 20 years or older, with atrial fibrillation diagnosed before 1 January 2012. Eligible subjects had no prior stroke or TIA, were not on anticoagulants at baseline, and had at least one blood cell count performed in 2011. The cohort (32,912 subjects) was followed

EvidenceUpdates2016

232. The prediction of postoperative stroke or death in patients with preoperative atrial fibrillation undergoing non-cardiac surgery: a VISION sub-study

The prediction of postoperative stroke or death in patients with preoperative atrial fibrillation undergoing non-cardiac surgery: a VISION sub-study 26270168 2015 10 06 2016 08 04 2015 10 06 1538-7836 13 10 2015 Oct Journal of thrombosis and haemostasis : JTH J. Thromb. Haemost. The prediction of postoperative stroke or death in patients with preoperative atrial fibrillation undergoing non-cardiac surgery: a VISION sub-study. 1768-75 10.1111/jth.13110 The optimal means of pre-operative risk (...) stratification in patients with atrial fibrillation (AF) is uncertain. To examine the accuracy of AF thromboembolic risk models (the CHADS2, CHA2DS2-VASc, and R2CHADS2 scores) for predicting 30-day stroke and/or all-cause mortality after non-cardiac surgery in patients with preoperative AF, and to compare these risk scores with the Revised Cardiac Risk Index (RCRI). A multicentre (8 countries, 2007-2011) prospective cohort study of patients ≥ 45 years of age undergoing inpatient non-cardiac surgery, who were

EvidenceUpdates2016

233. Percutaneous left appendage closure to reduce stroke risk in patients with atrial fibrillation

Percutaneous left appendage closure to reduce stroke risk in patients with atrial fibrillation Percutaneous left appendage closure to reduce stroke risk in patients with atrial fibrillation Percutaneous left appendage closure to reduce stroke risk in patients with atrial fibrillation HAYES, Inc. Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation HAYES, Inc (...) .. Percutaneous left appendage closure to reduce stroke risk in patients with atrial fibrillation. Lansdale: HAYES, Inc.. Directory Publication. 2015 Final publication URL The report may be purchased from: Indexing Status Subject indexing assigned by CRD MeSH Atrial Appendage; Atrial Fibrillation; Humans; Stroke; Warfarin Language Published English Country of organisation United States English summary An English language summary is available. Address for correspondence HAYES, Inc., 157 S. Broad Street, Suite

Health Technology Assessment (HTA) Database.2015

234. Atrial Fibrillation - Diagnosis and Management

Atrial Fibrillation - Diagnosis and Management Atrial Fibrillation - Diagnosis and Management - Province of British Columbia Search default_collection default_frontend MENU theme_1_collection theme_1_frontend theme_1_collection theme_1_frontend British Columbians & Our Governments theme_3_collection theme_3_frontend theme_3_collection theme_3_frontend Health theme_2_collection theme_2_frontend theme_2_collection theme_2_frontend Birth, Adoption, Death, Marriage & Divorce theme_4_collection (...) theme_14_collection theme_14_frontend theme_14_collection theme_14_frontend Tourism & Immigration theme_15_collection theme_15_frontend theme_15_collection theme_15_frontend Family & Social Supports default_collection default_frontend default_collection default_frontend Data Section Navigation Atrial Fibrillation - Diagnosis and Management Effective Date: April 1, 2015 Recommendations and Topics Scope This guideline provides recommendations for the diagnosis and management of atrial fibrillation (AF) including

Clinical Practice Guidelines and Protocols in British Columbia2015

235. Use of Non-Vitamin K Antagonist Oral Anticoagulants (NOAC) in Non-Valvular Atrial Fibrillation

Use of Non-Vitamin K Antagonist Oral Anticoagulants (NOAC) in Non-Valvular Atrial Fibrillation Use of Non-Vitamin K Antagonist Oral Anticoagulants (NOAC) in Non-Valvular Atrial Fibrillation - Province of British Columbia Search default_collection default_frontend MENU theme_1_collection theme_1_frontend theme_1_collection theme_1_frontend British Columbians & Our Governments theme_3_collection theme_3_frontend theme_3_collection theme_3_frontend Health theme_2_collection theme_2_frontend (...) theme_13_frontend theme_13_collection theme_13_frontend Employment, Business & Economic Development theme_14_collection theme_14_frontend theme_14_collection theme_14_frontend Tourism & Immigration theme_15_collection theme_15_frontend theme_15_collection theme_15_frontend Family & Social Supports default_collection default_frontend default_collection default_frontend Data Section Navigation Use of Non-Vitamin K Antagonist Oral Anticoagulants (NOAC) in Non-Valvular Atrial Fibrillation Effective Date: April 1

Clinical Practice Guidelines and Protocols in British Columbia2015

236. Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study.

Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study. STUDY QUESTION: What are the risks of all cause mortality, thromboembolism, major bleeding, and recurrent gastrointestinal bleeding associated with restarting antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation? METHODS: This Danish cohort study (1996-2012) included all patients (...) with atrial fibrillation discharged from hospital after gastrointestinal bleeding while receiving antithrombotic treatment. Restarted treatment regimens were single or combined antithrombotic drugs with oral anticoagulation and antiplatelets. Follow-up started 90 days after discharge to avoid confounding from use of previously prescribed drugs on discharge. Risks of all cause mortality, thromboembolism, major bleeding, and recurrent gastrointestinal bleeding were estimated with competing risks models and time

BMJ2015

237. A Clinical Decision Instrument for 30-Day Death After an Emergency Department Visit for Atrial Fibrillation: The Atrial Fibrillation in the Emergency Room (AFTER) Study

A Clinical Decision Instrument for 30-Day Death After an Emergency Department Visit for Atrial Fibrillation: The Atrial Fibrillation in the Emergency Room (AFTER) Study 26387928 2015 11 23 2016 04 11 2015 11 23 1097-6760 66 6 2015 Dec Annals of emergency medicine Ann Emerg Med A Clinical Decision Instrument for 30-Day Death After an Emergency Department Visit for Atrial Fibrillation: The Atrial Fibrillation in the Emergency Room (AFTER) Study. 658-668.e6 10.1016/j.annemergmed.2015.07.017 S0196 (...) -0644(15)00595-8 The high volume of patients treated in an emergency department (ED) for atrial fibrillation is predicted to increase significantly in the next few decades. Currently, 11% of these patients die within a year. We sought to derive and validate a complex model and a simplified model that predicts mortality in ED patients with atrial fibrillation. This population-based, retrospective cohort study included 3,510 adult patients with a primary diagnosis of atrial fibrillation who were

EvidenceUpdates2015

238. The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation

The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation 26424865 2015 12 08 2016 09 19 2016 10 19 1522-9645 36 46 2015 Dec 07 European heart journal Eur. Heart J. The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation. 3258-64 10.1093/eurheartj/ehv476 Therapeutic decisions in atrial fibrillation (AF) are often influenced by assessment of bleeding risk. However, existing bleeding risk scores have limitations. We (...) sought to develop and validate a novel bleeding risk score using routinely available clinical information to predict major bleeding in a large, community-based AF population. We analysed data from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF), a prospective registry that enrolled incident and prevalent AF patients at 176 US sites. Using Cox proportional hazards regression, we identified factors independently associated with major bleeding among patients taking oral

EvidenceUpdates2015

239. Edoxaban (Lixiana) - for prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (NVAF) with one or more risk factors

Edoxaban (Lixiana) - for prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (NVAF) with one or more risk factors

Scottish Medicines Consortium2015

240. Patients With Ischemic Stroke and Incident Atrial Fibrillation: A Nationwide Cohort Study

Patients With Ischemic Stroke and Incident Atrial Fibrillation: A Nationwide Cohort Study 26251249 2015 08 25 2015 11 23 2016 11 22 1524-4628 46 9 2015 Sep Stroke Stroke Patients With Ischemic Stroke and Incident Atrial Fibrillation: A Nationwide Cohort Study. 2432-7 10.1161/STROKEAHA.115.010270 A substantial part of ischemic strokes is attributed to atrial fibrillation (AF). We hypothesized that patients with ischemic stroke without prior diagnosed AF were at higher risk of having a subsequent (...) diagnosis of AF, and this was associated with multiple risk factors. This French longitudinal cohort study was based on the national database covering hospital care from 2008 to 2012 for the entire population. Of 65 807 patients with ischemic stroke in 2009, 48 992 did not have AF at baseline. A total of 4828 of these patients were diagnosed as having AF during a follow-up of 15±15 months (incidence rate 7.9 per 100 person-years). By comparison, the yearly rate of new-onset AF for the 826 416 patients

EvidenceUpdates2015